<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T11:29:15Z</responseDate>
  <request identifier="oai:figshare.com:article/34035286" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34035286</identifier>
        <datestamp>2026-09-30T17:32:55Z</datestamp>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Comparative analysis of clinicopathological parameters between the high and low CALLY index groups.&lt;/p&gt;</dc:title>
          <dc:creator>Tomonari Shimagaki (10177670)</dc:creator>
          <dc:creator>Atsushi Maeda (436456)</dc:creator>
          <dc:creator>Tomoya Harima (25145290)</dc:creator>
          <dc:creator>Akihiro Sakai (81092)</dc:creator>
          <dc:creator>Rumi Matono (25145293)</dc:creator>
          <dc:creator>Naotaka Hashimoto (25145296)</dc:creator>
          <dc:creator>Shohei Yamaguchi (3833263)</dc:creator>
          <dc:creator>Kozo Konishi (25145299)</dc:creator>
          <dc:creator>Kenkichi Hashimoto (25145302)</dc:creator>
          <dc:creator>Takashi Maeda (145189)</dc:creator>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>severe postoperative complications</dc:subject>
          <dc:subject>readily available biomarkers</dc:subject>
          <dc:subject>multivariate analysis identified</dc:subject>
          <dc:subject>integrate host inflammatory</dc:subject>
          <dc:subject>40 &amp;# 8211</dc:subject>
          <dc:subject>37 &amp;# 8211</dc:subject>
          <dc:subject>significantly poorer dfs</dc:subject>
          <dc:subject>low cally index</dc:subject>
          <dc:subject>cally index groups</dc:subject>
          <dc:subject>lower albumin levels</dc:subject>
          <dc:subject>crp )- albumin</dc:subject>
          <dc:subject>high cally index</dc:subject>
          <dc:subject>significantly worse dfs</dc:subject>
          <dc:subject>low (&lt; 2</dc:subject>
          <dc:subject>preoperative cally index</dc:subject>
          <dc:subject>high (≥ 2</dc:subject>
          <dc:subject>underwent hepatic resection</dc:subject>
          <dc:subject>hr ), 1</dc:subject>
          <dc:subject>ci ), 1</dc:subject>
          <dc:subject>cally index</dc:subject>
          <dc:subject>dfs ),</dc:subject>
          <dc:subject>worse dfs</dc:subject>
          <dc:subject>underwent resection</dc:subject>
          <dc:subject>high risk</dc:subject>
          <dc:subject>higher crp</dc:subject>
          <dc:subject>fetoprotein levels</dc:subject>
          <dc:subject>hepatic resection</dc:subject>
          <dc:subject>preoperative c</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>score matching</dc:subject>
          <dc:subject>remains frequent</dc:subject>
          <dc:subject>reactive protein</dc:subject>
          <dc:subject>prognostic significance</dc:subject>
          <dc:subject>prognostic factors</dc:subject>
          <dc:subject>overall survival</dc:subject>
          <dc:subject>lymphocyte index</dc:subject>
          <dc:subject>larger tumors</dc:subject>
          <dc:subject>independently associated</dc:subject>
          <dc:subject>hepatocellular carcinoma</dc:subject>
          <dc:subject>hazard ratio</dc:subject>
          <dc:subject>free survival</dc:subject>
          <dc:subject>confidence interval</dc:subject>
          <dc:description>&lt;p&gt;Comparative analysis of clinicopathological parameters between the high and low CALLY index groups.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:32:45Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358776.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Comparative_analysis_of_clinicopathological_parameters_between_the_high_and_low_CALLY_index_groups_p_/34035286</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
